Covid-19 roundup: FDA re­port­ed­ly set to au­tho­rize No­vavax jab; As­traZeneca says its shot just as ef­fec­tive as mR­NA

Though No­vavax has been go­ing down a wind­ing path to get a EUA from the FDA, the Mary­land-based biotech may soon be re­ceiv­ing some good news.

Ac­cord­ing to a re­port from Politi­co, the FDA is ex­pect­ed to au­tho­rize No­vavax’s Covid-19 vac­cine for emer­gency use as ear­ly as Wednes­day. This is ac­cord­ing to two peo­ple with knowl­edge of the mat­ter who told the news site. Politi­co stat­ed that the com­pa­ny still needs to com­plete a fi­nal round of qual­i­ty test­ing for its vac­cine over the next sev­er­al days.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER